The Role of Epidemiology and Biostatistics in Health News Reporting

Public Health in the 21st Century: Volume 1-3

Volumn 1-3, Issue , 2010, Pages 161-190

  Trushin, Paula ^b   Bang, Heejung ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85172067115     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (100)

1. ScienceDaily. Highly active compound found in coffee may prevent colon cancer. http://www.sciencedaily.com/releases/2003/10/031015031251.htm. Published October 15, 2003. Accessed October 19, 2009.
2. Furtado M. The surprising ingredient causing weight gain. YAHOO!_C HEALTH. http://health.yahoo.com. Published July 27, 2009. Accessed July 30, 2009.
3. Devlin K. Three cups of brewed coffee a day ‘triples risk of hallucinations.' Telegraph. co.uk. http://www.telegraph.co.uk/science/science-news. Published January 14, 2009. Accessed September 27, 2009.
4. Beck M. Correlation, causation and what Welsh rugby means for the Pope. The Wall Street Journal. http://blogs.wsj.com/health/2009/01/27/. Published January 27, 2009. Accessed October 16, 2009.
5. von Bubnoff A. Numbers can lie: good today, but how about tomorrow? Los Angeles Times. Health page. http://articles.latimes.com/2007. Published September 17, 2007. Accessed February 2, 2009.
6. Angell M. Science on Trial. The Clash of Medical Evidence and the Law in the Breast Implant Case. London: W. W. Norton & Company; 1996.
7. Narasimhan MG. Controversy in science. J Biosci. 2001;26:299-304.
8. Stocking AH, Holstein LW. Manufacturing doubt: journalists’ roles and the construction of ignorance in a scientific controversy. Public Understand Sci. 2009;18:23-42.
9. Ceccarelli L. Manufactured controversy: Science Studies Network (SSNet) Seminar; October 20, 2008; University of Washington, Seattle, WA. http://depts.washington. edu/ssnet/handout_102008.pdf. Accessed October 28, 2009.
10. Wilby P. The media’s addiction to controversy can seriously damage your health. The Guardian. http://www.guardian.co.uk. Published August 13, 2008. Accessed April 29, 2009. Correction published on August 21, 2008. The Guardian.
11. Ransohoff DF, Ransohoff RM. Sensationalism in the media: when scientists and journalists may be complicit collaborators. EFF Clin Pract. 2001;4:185-188.
12. Greer K. Journalists forced to sensationalize science to attract readers. Tennessee Journalist. http://tnjn.com/2008/mar/27/journalists-forced-to-sensatio/. Published March 27, 2008. Accessed September 28, 2009.
13. Shuchman M, Wilkes MS. Medical scientists and health news reporting: a case of miscommunication. Ann Intern Med. 1997;126:976-982.
14. Rothman SM, Rothman DJ. Marketing HPV vaccine. Implications for adolescent health and medical professionalism. JAMA. 2009;302:781-786.
15. Jackson T. News skews health priorities, study claims. BMJ. 2003;327:688.
16. Sharma V, Dowd D, Swanson DS, Slaughter AJ, Simon SD. Influence of the news media on diagnostic testing in the emergency department. Arch Pediatr Adolesc Med. 2003;157:257-260.
17. Schield M. Statistical literacy and liberal education at Augsburg College. Peer Rev 2004. http://www.aacu-edu.org/peerreview/index.cfm. Accessed May 14, 2009.
18. University of California Museum of Paleontology. '‘Misconceptions about science:'' understanding science. http://undsci.berkeley.edu/teaching/misconceptions.php. Retrieved May 19, 2009.
19. Martin A, Faraone SV, Henderson SW, et al. Mission statement: advancing the science of pediatric mental health and promoting the care of youth and their families. J Am Acad Child Adolesc Psychiatry. 2008;47:1.
20. Norton JD. Science and uncertainty. Synthese. 1994;99:3-22.
21. Moore DS. Statistics among the liberal arts. J Am Stat Assoc. 1998;93:1253-1259.
22. Campbell SK. Flaws and Fallacies in Statistical Thinking. Mineola, NY: Dover Publications, Inc.; 2002.
23. Feynman RP. Uncertainty in science. In: The Meaning of It All: Thoughts of a Citizen-Scientist. New York: Basic Books: 2005.
24. Wild CJ, Pfannkuch M. Statistical thinking in empirical enquiry. Intl Stat Rev. 1999;67:223-265.
25. Pellegrin P. Physics. In: Brunschwig J, Lloyd GER, eds. The Greek Pursuit of Knowledge. Cambridge, MA: The Belknap Press of Harvard University Press; 2000: xiii, 282-300.
26. Kuhn JE, Greenfield MVH, Wojtys EM. A statistics primer: hypothesis testing. Am J Sports Med. 1996;24:702-703.
27. Gould SJ. Evolution as fact and theory (abridged). In: Vetter HF, ed. Speak Out Against the New Right. Boston, MA: Beacon Press; 1982.
28. Parascandola M, Weed DL. Causation in epidemiology. J Epidemiol Community Health. 2001;55:905-912.
29. Shugan SM. Causality, unintended consequences and deducing shared causes. Market Sci. 2007;26:731-741.
30. Vandenbroucke JP. The history of confounding. Soz-Pr€aventivmed. 2002;47:216-224.
31. Kestenbaum B. Epidemiology and Biostatistics. An Introduction to Clinical Research. New York: Springer Publications; 2009.
32. Szklo M, Nieto FJ. Epidemiology: Beyond the Basics. 2nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2006.
33. Mayhall CG. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia, PA:Lippincott Williams & Wilkins; 2004.
34. Bernstein PL. Against the Gods. The Remarkable Story of Risk. New York: John Wiley & Sons, Inc.; 1998.
35. Wikipedia: The Free Encyclopedia. Number needed to treat. http://en.wikipedia.org/wiki/Number_needed_to_treat. Accessed September 28, 2009.
36. Trial AIDS vaccine cuts infection risk 31 percent. CBS News. http://www.cbsnews.com/stories/2009/09/24/health/main5334317.shtml. Published September 24, 2009. Accessed October 18, 2009.
37. Henderson GE, Churchill LR, Davis AM, et al. Clinical trials and medical care:defining the therapeutic misconception. PloS Med. 2007;4(11):xxe324. doi:10.1371/journal.pmed.0040324. http://www.ncbi.nlm.nih.gov/. Accessed October 25, 2009.
38. Garbe E, Suissa S. Issues to debate on the Women’s Health Initiative (WHI) study. Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum Reproduction. 2004;19:8-13.
39. Hess DR. Retrospective studies and chart reviews. Respir Care. 2004;49:1171-1174.
40. Humphrey L, Chan BKS, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med. 2002;137:273-284.
41. Simon SD. Understanding the odds ratio and the relative risk. J Andrology. 2001;22:533-536.
42. Pouwels S, Lalmohamed A, Leufkens B, et al. Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke. 2009;40:3281-3285.
43. Edelson E. Stroke doubles risk of hip, thigh fractures. Preventive measures urgently needed, researcher says. U.S. News & World Report. http://health.usnews.com/articles/health/healthday/2009/08/06/stroke-doubles-risk-of-hip-thigh-fractures.html. Published August 6, 2009. Accessed August 23, 2009.
44. Moye LA. Multiple Analyses in Clinical Trials: Fundamentals for Investigators. New York: Springer Publications; 2003.
45. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892.
46. Mahid SS, Hornung CA, Minor KS, Turina M, Galandiuk S. Systematic reviews and meta-analysis for the surgeon scientist. Br J Surg. 2006;93:1315-1324.
47. Salmond SS. Randomized controlled trials: methodological concepts and critique. Orthop Nurs. 2008;27:116-122.
48. Thisted RA. What is a p-value? Department of Statistics, University of Chicago. http://galton.uchicago.edu/_thisted/Distribute/pvalue.pdf. Published May 25, 1998. Retrieved September 30, 2009.
49. Burns N, Grove SK. Understanding Nursing Research. Building an Evidence-Based Practice. 3rd ed. Philadelphia, PA: WB Saunders; 2002.
50. Ioannidis JPA. Large scale evidence and replication: insights from rheumatology and beyond. Ann Rheum Dis. 2005;64:345-346.
51. Boyer CB. The History of the Calculus and Its Conceptual Development. New York:Dover Publications, Inc.; 1949.
52. Boffetta P, McLaughlin JK, La Vecchia C, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst. 2008;100:988-995.
53. Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol. 2008;101[suppl]:14DS-19D.
54. Parascandola M. Two approaches to etiology: the debate over smoking and lung cancer in the 1950s. Endeavour. 2004;28:81-86.
55. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300. http://www.edwardtufte.com/tufte/hill.
56. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins: 2008.
57. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998.
58. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95:S144-S150.
59. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605-613.
60. Temple RJ. A regulatory authority’s opinion about surrogate endpoints. In: Nimmo WS, Tucker GT, eds. Clinical Measurement in Drug Evaluation. New York: J. Wiley; 1995.
61. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605-613.
62. Weinberg CR. It’s time to rehabilitate the p-value. Epidemiology. 2001;12:288-290.
63. Graham DJ. Cox-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA. 2006;296:1653-1656.
64. Lesaffre E. Use and misuse of the p-value. Bull NYU Hosp Joint Dis. 2008;66:146-149.
65. Drotar D. Thoughts on establishing research significance and preserving scientific integrity. J Pediatr Psychol. 2008;33:1-5.
66. Peck CC. The almighty p-value or the significance of '‘significance’'. Present Concepts Intern Med. 1971;4(11):1021-1024.
67. Ziliak ST, McCloskey DN. The Cult of Statistical Significance: How the Standard Error Costs Us Jobs, Justice, and Lives. Ann Arbor: University of Michigan Press; 2008.
68. Goodman SN. Of p-values and Bayes: a modest proposal. Epidemiology. 2001;12:295-297.
69. Editors. The value of p. Epidemiology. 2001;12:286.
70. du Prel J-B, Hommel G, Röhrig B, Blettner M. Confidence interval or p-value. Dtsch Arztebl Int. 2009;106:335-339.
71. Curran-Everett D. Explorations in statistics: confidence intervals. Adv Physiol Educ. 2009;33:87-90.
72. Simon SD. Interpreting negative studies. J Andrology. 2001;22:13-16.
73. Jacobson NS, Follette WC, Revenstorf D. Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance. Behav Ther. 1984;15:336-352.
74. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12-19.
75. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189-2194.
76. Young SS, Bang H, Oktay K. Cereal-induced gender selection? Most likely a multiple testing false positive. Proc R Soc B. 2009;276:1211-1222.
77. Lawson DH. Detection of drug-induced disease. Br J Clin Pharmacol. 1979;7:13-18.
78. Ross RK, Paganini-Hill A, Krailo MD, Gerkins VR, Henderson BE. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women. Cancer Res. 1984;44:3106-3108.
79. Shapiro S. Looking to the 21st century: have we learned from our mistakes, or are we doomed to compound them? Pharmacoepidemiol Drug Safety. 2004;13:257-265.
80. Garcia LV. Escaping the Bonferroni iron claw in ecological studies. Oikos. 2004;105:657-663.
81. Ware JH. The National Emphysema Treatment Trial-how strong is the evidence? [Perspective] N Engl J Med. 2003;348:2055-2056.
82. Jadad A. Randomised Controlled Trials: A User’s Guide. London: BMJ Books; 1998.
83. White PF, Watcha MF. Has the use of meta-analysis enhanced our understanding of therapies for postoperative nausea and vomiting? Anesth Analg. 1999;88:1200-1202.
84. Naylor CD. Meta-analysis and the meta-epidemiology of clinical research. BMJ. 1997;315:617-619.
85. Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol. 2004;34:717-721.
86. Hamer RM, Simpson PM. SAS1 Tools for Meta-Analysis. http://www2.sas.com/proceedings/sugi27/p250-27.pdf. Accessed September 27, 2009. SAS1 Paper No.250-27.
87. Hux JE, Naylor CD. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients’ acceptance of treatment? Med Decis Making. 1995;15:152-157.
88. Carling CLL, Kristoffersen DT, Montori VM, et al. The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial. PLoS Med. 2009;6(8):e1000134. doi:10.1371/journal.pmed.1000134. www.plosmedicine.org. Accessed September 23, 2009.
89. Crewdson J. Statistics misleading, some doctors say: relative numbers skew benefit to look much larger. Chicago Tribune. March 15, 2002: 21.
90. Sorensen L, Gyrd-Hansen D, Kristiansen IS, Nexoe J. Laypersons understanding of relative risk reductions: randomized cross-sectional study. BMC Med Inform Dec Making. 2008;8:1-7. http://www.biomedcentral.com.
91. Winstein K. Medicine’s dangerous guessing game. Wall Street Journal. http://online.wsj.com. Published September 9, 2009. Accessed September 9, 2009.
92. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009;302:750-757.
93. Haug C. The risks and benefits of HPV vaccination. JAMA. 2009;302:795-796.
94. World Health Organization. Publication bias in clinical trials due to statistical significance or direction of trial results. RHL: The WHO Reproductive Health Library. http://apps.who.int/rhl/education/MR000006_butlerpa_com/en/index.html. Accessed September 23, 2009.
95. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
96. PLoS Medicine Editors. An unbiased scientific record should be everyone’s agenda. PLoS Med. 2009;6(2):e1000038. doi:10.1371/journal.pmed.1000038. http://www.plosmedicine.org/. Accessed September 23, 2009.
97. Freedman DA, Pettiti DB. Hormone replacement therapy does not save lives. Comments on the Women’s Health Initiative. Biometrics. 2005;62:918-920.
98. Public Library of Science. PLoS core principles. http://www.plos.org/about/principles.html. Accessed September 23, 2009.
99. Eisen MB, Brown PO, Varmus HE. PLOS Medicine: a medical journal for the internet age. PLOS Med. 2004;1(1):e31. http://www.ncbi.nlm.nih.gov. Accessed October 25, 2009.
100. Begley S. Lies, damned lies and… Newsweek. http://www.newsweek.com. Published July 12, 2008. Accessed September 22, 2009.